BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uchiyama K, Takami S, Suzuki H, Umeki K, Mochizuki S, Kakinoki N, Iwamoto J, Hoshino Y, Omori J, Fujimori S, Yanaka A, Mizokami Y, Ohkusa T. Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: An investigator-initiated multicenter double-blind clinical trial. PLoS One 2020;15:e0241337. [PMID: 33151988 DOI: 10.1371/journal.pone.0241337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Shi J, Weng JH, Mitchison TJ. Immunomodulatory drug discovery from herbal medicines: Insights from organ-specific activity and xenobiotic defenses. Elife 2021;10:e73673. [PMID: 34779403 DOI: 10.7554/eLife.73673] [Reference Citation Analysis]
2 Schulz-Kuhnt A, Neurath MF, Wirtz S, Atreya I. Innate Lymphoid Cells as Regulators of Epithelial Integrity: Therapeutic Implications for Inflammatory Bowel Diseases. Front Med (Lausanne) 2021;8:656745. [PMID: 33869257 DOI: 10.3389/fmed.2021.656745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Fernández-Gallego N, Sánchez-Madrid F, Cibrian D. Role of AHR Ligands in Skin Homeostasis and Cutaneous Inflammation. Cells 2021;10:3176. [PMID: 34831399 DOI: 10.3390/cells10113176] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Saiki JP, Andreasson JO, Grimes KV, Frumkin LR, Sanjines E, Davidson MG, Park KT, Limketkai B. Treatment-refractory ulcerative colitis responsive to indigo naturalis. BMJ Open Gastroenterol 2021;8:e000813. [PMID: 34969665 DOI: 10.1136/bmjgast-2021-000813] [Reference Citation Analysis]